MA46426A - Biomatériaux à base de glycosaminoglycanes sulfatés utilisés en tant que mimétiques de protéoglycanes - Google Patents

Biomatériaux à base de glycosaminoglycanes sulfatés utilisés en tant que mimétiques de protéoglycanes

Info

Publication number
MA46426A
MA46426A MA046426A MA46426A MA46426A MA 46426 A MA46426 A MA 46426A MA 046426 A MA046426 A MA 046426A MA 46426 A MA46426 A MA 46426A MA 46426 A MA46426 A MA 46426A
Authority
MA
Morocco
Prior art keywords
glycosaminoglycane
sulphated
proteoglycan
mimetics
biomaterials used
Prior art date
Application number
MA046426A
Other languages
English (en)
Inventor
Thomas H Jozefiak
Original Assignee
Glycologix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycologix Llc filed Critical Glycologix Llc
Publication of MA46426A publication Critical patent/MA46426A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
    • C07C317/08—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/005—Crosslinking of cellulose derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA046426A 2016-09-16 2017-09-15 Biomatériaux à base de glycosaminoglycanes sulfatés utilisés en tant que mimétiques de protéoglycanes MA46426A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662395805P 2016-09-16 2016-09-16

Publications (1)

Publication Number Publication Date
MA46426A true MA46426A (fr) 2019-07-24

Family

ID=61619817

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046426A MA46426A (fr) 2016-09-16 2017-09-15 Biomatériaux à base de glycosaminoglycanes sulfatés utilisés en tant que mimétiques de protéoglycanes

Country Status (7)

Country Link
US (2) US11090327B2 (fr)
EP (1) EP3512561A4 (fr)
JP (2) JP7619759B2 (fr)
AU (2) AU2017326009B2 (fr)
CA (1) CA3035659C (fr)
MA (1) MA46426A (fr)
WO (1) WO2018053276A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021237704A1 (en) * 2020-03-19 2022-10-13 Glycologix, Inc. Sulfated glycosaminoglycan biomaterials as proteoglycan mimics
SE545148C2 (en) 2020-06-29 2023-04-18 Antaros Tracer Ab Novel compounds for use in diagnosis and/or monitoring of fibrosis
CN116874830B (zh) * 2023-05-31 2024-02-27 山东丰金美业科技有限公司 一种romp聚合反应交联的透明质酸材料及制备与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61164558A (ja) * 1985-01-17 1986-07-25 生化学工業株式会社 医療用成形物の成形材料
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
ATE135584T1 (de) * 1988-12-20 1996-04-15 Jolla Cancer Res Found Polypeptid-polymer-konjugate mit wundheilender wirkung
JPH11507679A (ja) * 1995-06-06 1999-07-06 シー．アール．バード，インコーポレイティド 水溶性ポリマーの粒子の水性分散液の製造法および得られた粒子
US6281341B1 (en) * 1997-04-30 2001-08-28 Biomm, Inc. & University Of Miami Hetero-polysaccharide conjugate and methods of making and using the same
FI974321A0 (fi) * 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US20040161476A1 (en) * 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
EP1607405B1 (fr) * 2003-03-11 2011-05-04 Seikagaku Corporation Composition polysaccharide photoreticulee et procede de fabrication
ITMI20061030A1 (it) * 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
CA2671572C (fr) * 2006-12-04 2015-05-26 Johns Hopkins University Adhesif biopolymere imide et hydrogel
US8383156B2 (en) * 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
US8912149B1 (en) * 2007-11-28 2014-12-16 California Institute Of Technology Glycosaminoglycan mimetics
US20150306237A1 (en) * 2012-12-19 2015-10-29 University Of Geneva Hyaluronic acid-antioxidant conjugates and their uses
BR112015022917A2 (pt) * 2013-03-15 2017-07-18 Symic Biomedical Inc peptidoglicanos sintéticos componentes da matriz extracelular
US20160051692A1 (en) * 2013-04-18 2016-02-25 Drexel University Novel methods of use of biomimetic proteoglycans
ES2811269T3 (es) * 2014-01-31 2021-03-11 Seikagaku Kogyo Co Ltd Agente de reticulación de diamina, cuerpo reticulado de polisacárido ácido y material médico
US20170072096A1 (en) * 2014-03-16 2017-03-16 Drexel University Novel hydrogels and methods using same
EP3040117A1 (fr) * 2014-12-29 2016-07-06 Galderma S.A. Hydrogels de sulfate de chondroïtine réticulée par éther et leur utilisation pour des applications de tissu mou
EP3187510A1 (fr) * 2015-12-29 2017-07-05 Galderma S.A. Réticulation de glucides

Also Published As

Publication number Publication date
JP2023123417A (ja) 2023-09-05
EP3512561A4 (fr) 2020-10-07
JP2019529645A (ja) 2019-10-17
US11975019B2 (en) 2024-05-07
CA3035659A1 (fr) 2018-03-22
JP7619759B2 (ja) 2025-01-22
CA3035659C (fr) 2022-09-06
US20220000905A1 (en) 2022-01-06
EP3512561A1 (fr) 2019-07-24
WO2018053276A1 (fr) 2018-03-22
AU2017326009B2 (en) 2020-11-12
AU2017326009A1 (en) 2019-03-28
US20190262386A1 (en) 2019-08-29
AU2021200256A1 (en) 2021-03-18
US11090327B2 (en) 2021-08-17
AU2021200256B2 (en) 2022-10-27

Similar Documents

Publication Publication Date Title
EP3718138C0 (fr) Unité de del pour affichage
EP3631544A4 (fr) Commutateur de faisceau optique tout-fibre
EP3398565A4 (fr) Endoprothèse vasculaire à lumière
EP3500820A4 (fr) Projecteur de lumière structurée
IL268902B (en) Assembling a compact anamorphic objective lens
EP3714838A4 (fr) Stent couvert à chambres multiples
EP3544184A4 (fr) Interrupteur de clavier mécanique mince
EP3438719A4 (fr) Unité à lentille
EP3368600A4 (fr) Compositions de revêtement à base aqueuse
EP3245293A4 (fr) Production de compositions à base de rhamnolipides
EP3411157A4 (fr) Revêtements résistants à la buée
EP3676655A4 (fr) Projection de lumière structurée
EP3435131A4 (fr) Unité de lentille
DK3415966T3 (da) Optisk afbryder
EP3443043A4 (fr) Compositions de prétraitement
PL3393818T3 (pl) Etykieta samomaskująca
EP3623855A4 (fr) Unité de lentille
EP3405542A4 (fr) Compositions adhésives optiquement transparentes à double durcissement
DE112018002743A5 (de) Optisches arbeitsplatzstatusanzeigesystem
EP3500793A4 (fr) Panneau lumineux à led de rattrapage
EP3368620A4 (fr) Composition de revêtement à base de polyuréthane
EP3390156A4 (fr) Mécanisme bimodal à commutateur optique
MA46426A (fr) Biomatériaux à base de glycosaminoglycanes sulfatés utilisés en tant que mimétiques de protéoglycanes
IL251199A0 (en) Direct-bonded optical coatings
EP3438718A4 (fr) Unité de lentille